9-34372349-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020702.5(MYORG):​c.595C>A​(p.Arg199Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0347 in 1,598,822 control chromosomes in the GnomAD database, including 1,176 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 101 hom., cov: 33)
Exomes 𝑓: 0.035 ( 1075 hom. )

Consequence

MYORG
NM_020702.5 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.81

Publications

6 publications found
Variant links:
Genes affected
MYORG (HGNC:19918): (myogenesis regulating glycosidase (putative)) Predicted to enable hydrolase activity, hydrolyzing O-glycosyl compounds. Involved in skeletal muscle fiber development. Predicted to be located in endoplasmic reticulum membrane and nuclear membrane. Implicated in basal ganglia calcification. [provided by Alliance of Genome Resources, Apr 2022]
MYORG Gene-Disease associations (from GenCC):
  • basal ganglia calcification, idiopathic, 7, autosomal recessive
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Illumina
  • bilateral striopallidodentate calcinosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015852451).
BP6
Variant 9-34372349-G-T is Benign according to our data. Variant chr9-34372349-G-T is described in ClinVar as [Benign]. Clinvar id is 1164440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.029 (4416/152274) while in subpopulation NFE AF = 0.0408 (2771/68000). AF 95% confidence interval is 0.0395. There are 101 homozygotes in GnomAd4. There are 2220 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 101 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYORGNM_020702.5 linkc.595C>A p.Arg199Ser missense_variant Exon 2 of 2 ENST00000297625.8 NP_065753.2 Q6NSJ0
MYORGXM_011517966.4 linkc.595C>A p.Arg199Ser missense_variant Exon 2 of 2 XP_011516268.1 Q6NSJ0
MYORGXM_017014930.3 linkc.595C>A p.Arg199Ser missense_variant Exon 2 of 2 XP_016870419.1 Q6NSJ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYORGENST00000297625.8 linkc.595C>A p.Arg199Ser missense_variant Exon 2 of 2 1 NM_020702.5 ENSP00000297625.8 Q6NSJ0
MYORGENST00000379142.3 linkc.217-18C>A intron_variant Intron 1 of 1 5 ENSP00000368437.2 X6RA92

Frequencies

GnomAD3 genomes
AF:
0.0290
AC:
4417
AN:
152156
Hom.:
101
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00632
Gnomad AMI
AF:
0.0680
Gnomad AMR
AF:
0.0217
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0147
Gnomad FIN
AF:
0.0743
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0407
Gnomad OTH
AF:
0.0249
GnomAD2 exomes
AF:
0.0297
AC:
6414
AN:
215868
AF XY:
0.0295
show subpopulations
Gnomad AFR exome
AF:
0.00644
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.0252
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0736
Gnomad NFE exome
AF:
0.0392
Gnomad OTH exome
AF:
0.0287
GnomAD4 exome
AF:
0.0353
AC:
51004
AN:
1446548
Hom.:
1075
Cov.:
71
AF XY:
0.0347
AC XY:
24961
AN XY:
718556
show subpopulations
African (AFR)
AF:
0.00520
AC:
172
AN:
33102
American (AMR)
AF:
0.0137
AC:
584
AN:
42624
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
652
AN:
25742
East Asian (EAS)
AF:
0.0000516
AC:
2
AN:
38730
South Asian (SAS)
AF:
0.0165
AC:
1386
AN:
84172
European-Finnish (FIN)
AF:
0.0732
AC:
3722
AN:
50828
Middle Eastern (MID)
AF:
0.00803
AC:
45
AN:
5602
European-Non Finnish (NFE)
AF:
0.0385
AC:
42610
AN:
1106004
Other (OTH)
AF:
0.0306
AC:
1831
AN:
59744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3254
6508
9763
13017
16271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1496
2992
4488
5984
7480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0290
AC:
4416
AN:
152274
Hom.:
101
Cov.:
33
AF XY:
0.0298
AC XY:
2220
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00628
AC:
261
AN:
41570
American (AMR)
AF:
0.0217
AC:
332
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.0147
AC:
71
AN:
4832
European-Finnish (FIN)
AF:
0.0743
AC:
789
AN:
10614
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0408
AC:
2771
AN:
68000
Other (OTH)
AF:
0.0246
AC:
52
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
228
457
685
914
1142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0348
Hom.:
177
Bravo
AF:
0.0237
ESP6500AA
AF:
0.00627
AC:
26
ESP6500EA
AF:
0.0351
AC:
293
ExAC
AF:
0.0268
AC:
3223
Asia WGS
AF:
0.00808
AC:
28
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 16, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MYORG-related disorder Benign:1
Feb 07, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.0012
T
Eigen
Benign
-0.17
Eigen_PC
Benign
0.067
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-0.98
T
PhyloP100
2.8
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.43
N
REVEL
Benign
0.10
Sift
Benign
0.18
T
Sift4G
Benign
0.53
T
Polyphen
0.010
B
Vest4
0.052
MPC
0.60
ClinPred
0.013
T
GERP RS
5.7
PromoterAI
-0.023
Neutral
Varity_R
0.21
gMVP
0.50
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12377; hg19: chr9-34372347; COSMIC: COSV99034396; API